Meeting
2015 Gastrointestinal Cancers Symposium
BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs).
Authors
Nitya Prabhakar Raj
Memorial Sloan Kettering Cancer Center, New York, NY
Nitya Prabhakar Raj , Paul A. Meyers , Leonard Saltz , Diane Lauren Reidy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 321)
DOI
10.1200/jco.2015.33.3_suppl.321
Abstract #
321
Poster Bd #
B42
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.
First Author: Nitya Prabhakar Raj
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.
First Author: Heloisa P. Soares
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A single-arm, phase II study of autophagy modulation using hydroxychloroquine in addition to encorafenib and cetuximab or panitumumab in metastatic BRAF-mutated colorectal cancer refractory to standard therapy.
First Author: Chetan Vakkalagadda
Poster
2017 Gastrointestinal Cancers Symposium
Pancreatic neuroendocrine tumors: A population-based analysis of epidemiology and outcomes.
First Author: Samer Alsidawi